Reelin was originally identified as a regulator of neuronal migration and synaptic function, but its non-neuronal functions have received far less attention. Reelin participates in organ development and physiological functions in various tissues, but it is also dysregulated in some diseases. In the cardiovascular system, Reelin is abundant in the blood, where it contributes to platelet adhesion and coagulation, as well as vascular adhesion and permeability of leukocytes. It is a pro-inflammatory and pro-thrombotic factor with important implications for autoinflammatory and autoimmune diseases such as multiple sclerosis, Alzheimer's disease, arthritis, atherosclerosis, or cancer. Mechanistically, Reelin is a large secreted glycoprotein that binds to several membrane receptors, including ApoER2, VLDLR, integrins, and ephrins. Reelin signaling depends on the cell type but mostly involves phosphorylation of NF-κB, PI3K, AKT, or JAK/STAT. This review focuses on non-neuronal functions and the therapeutic potential of Reelin, while highlighting secretion, signaling, and functional similarities between cell types.
Keywords: Alzheimer’s disease; ApoER2; CP: Cancer; CP: Immunology; JAK/STAT; NF-κB; PI3K/AKT; Reelin; VLDR; arthritis; atherosclerosis; cancer; coagulation; immune system; inflammation; intestine; kidney; leukocyte; liver; lymphatic circulation; multiple sclerosis; vascular system.
Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.